Sarcopenia as a predictor of future cognitive impairment in older adults
Open accessThe DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
OBJECTIVES: We investigated the association between the indices of sarcopenia and future risk of cognitive impairment in older adults. DESIGN: Community-based prospective cohort study. SETTING: Community. PARTICIPANTS: A total of 297 participants aged ≥65 years without cognitive impairment at baseline (mean age, 71.9 ± 6.6 years; men:women, 158:139) and who underwent cognitive evaluation at the 5-year follow-up. MEASUREMENTS: Sarcopenia parameters including appendicular lean mass (ALM), handgrip strength, and the Short Physical Performance Battery (SPPB) score at baseline were compared according to the later progression of mild cognitive impairment (MCI) and/or dementia. The operational criteria suggested by the Foundation for the National Institutes of Health Sarcopenia Project were used. We performed multivariate logistic regression analysis to identify the independent indicators of the progression of cognitive impairment. RESULTS: Among the 297 participants, 242 (81.5%) remained cognitively normal (nonprogression group), whereas 55 (18.5%) showed progression of cognitive impairment (50 subjects (16.8%) to MCI and 5 subjects (1.7%) to dementia) (progression group). Compared with the nonprogression group, subjects in the progression group were older, had a lower educational level, and had lower physical function as assessed by the SPPB; a higher percentage were depressed. Other baseline markers of sarcopenia, including the ALM-to-body mass index ratio and handgrip strength did not differ significantly between the groups. The association between a low SPPB score (<9) and progression of cognitive impairment was maintained after adjustment for conventional risk factors for cognitive impairment (hazard ratio 2.222, 95% confidence interval 1.047-4.716, P = 0.038). CONCLUSION: Decreased physical performance, as assessed by the SPPB, but not other markers of sarcopenia, was independently associated with the risk of later cognitive impairment in older adults.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Winblad, B., Palmer, K., Kivipelto, M., Jelic, V., Fratiglioni, L., Wahlund, L. ‐., Nordberg, A., Bäckman, L., Albert, M., Almkvist, O., et al. (2004) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2004.01380.x · Cited by 4,946
Studenski, S. A., Peters, K. W., Alley, D. E., Cawthon, P. M., McLean, R. R., Harris, T. B., Ferrucci, L., Guralnik, J. M., Fragala, M. S., Kenny, A. M., et al. (2014) · The Journals of Gerontology: Series A · doi:10.1093/gerona/glu010 · Cited by 2,545
Neuropathology of older persons without cognitive impairment from two community-based studies
Bennett, D. A., Schneider, J. A., Arvanitakis, Z., Kelly, J. F., Aggarwal, N. T., Shah, R. C., & Wilson, R. S. (2006) · Neurology · doi:10.1212/01.wnl.0000219668.47116.e6 · Cited by 1,336 · cited 1×
“Structural brain damage including neuropathological features of AD, cerebral infarction, and Lewy bodies lead to impaired physical function, although the cognitive domain was spared at the time of evaluation (46).”
Inflammatory markers and loss of muscle mass (sarcopenia) and strength
Schaap, L. A., Pluijm, S. M. F., Deeg, D. J. H., & Visser, M. (2006) · The American Journal of Medicine · doi:10.1016/j.amjmed.2005.10.049 · Cited by 1,047
The metabolic syndrome, inflammation, and risk of cognitive decline
Yaffe, K. (2004) · JAMA · doi:10.1001/jama.292.18.2237 · Cited by 1,025 · cited 1×
“High levels of these markers were associated with a 66% increase in the risk of cognitive impairment at the 4-year follow-up in one study (39).”
Inflammatory Markers and Physical Performance in Older Persons: The InCHIANTI Study
Cesari, M., Penninx, B. W. J. H., Pahor, M., Lauretani, F., Corsi, A. M., Williams, G. R., Guralnik, J. M., & Ferrucci, L. (2004) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/59.3.m242 · Cited by 901
Srikanthan, P., & Karlamangla, A. S. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-0435 · Cited by 785
Taekema, D. G., Gussekloo, J., Maier, A. B., Westendorp, R. G. J., & de Craen, A. J. M. (2010) · Age and Ageing · doi:10.1093/ageing/afq022 · Cited by 625
Craft, S. (2007) · Current Alzheimer Research · doi:10.2174/156720507780362137 · Cited by 487 · cited 1×
“Insulin resistance (40, 41), decreased sex steroid levels (42, 43), and elevated oxidative stress (44, 45) are also implicated in the association between physical function and cognitive dysfunction.”
Frailty is associated with incident Alzheimer's disease and cognitive decline in the elderly
Buchman, A. S., Boyle, P. A., Wilson, R. S., Tang, Y., & Bennett, D. A. (2007) · Psychosomatic Medicine · doi:10.1097/psy.0b013e318068de1d · Cited by 420 · cited 1×
“An increased composite frailty measure was associated with incident AD and the rate of cognitive decline in a 3-year follow-up study (12).”
Cited by
Sarcopenia and cognitive impairment: A systematic review and meta-analysis
Peng, T.-C., Chen, W.-L., Wu, L.-W., Chang, Y.-W., & Kao, T.-W. (2020) · Clinical Nutrition · doi:10.1016/j.clnu.2019.12.014 · Cited by 333
Implications of low muscle mass across the continuum of care: a narrative review
Prado, C. M., Purcell, S. A., Alish, C., Pereira, S. L., Deutz, N. E., Heyland, D. K., Goodpaster, B. H., Tappenden, K. A., & Heymsfield, S. B. (2018) · Annals of Medicine · doi:10.1080/07853890.2018.1511918 · Cited by 286
Differences in handgrip strength protocols to identify sarcopenia and frailty - a systematic review
Sousa-Santos, A. R., & Amaral, T. F. (2017) · BMC Geriatrics · doi:10.1186/s12877-017-0625-y · Cited by 273
Moon, J. H., Kim, K. M., Kim, J. H., Moon, J. H., Choi, S. H., Lim, S., Lim, J.-Y., Kim, K. W., Park, K. S., & Jang, H. C. (2016) · PLOS ONE · doi:10.1371/journal.pone.0166344 · Cited by 54
Self-citationGao, X., Chen, Y., & Cheng, P. (2024) · Frontiers in Physiology · doi:10.3389/fphys.2024.1338875 · Cited by 41
Metadata
- Authors
- Moon, J. H., Moon, J. H., Kim, K. M., Choi, S. H., Lim, S., Park, K. S., Kim, K. W., & Jang, H. C.
- Venue
- The Journal of nutrition, health and aging
- Publisher
- Elsevier BV
- Published
- 2016-05
- Volume
- 20
- Issue
- 5
- Pages
- 496-502
- ISSN
- 1279-7707 (ISSN-L)
- OpenAlex
- W2191136501
- Cited by
- 83
- References
- 12
- FWCI
- 2.37
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Sarcopenia as a predictor of future cognitive impairment in older adults. https://app.cochat.ai/papers/10.1007/s12603-015-0613-x
- The paper
- Moon, J. H., Moon, J. H., Kim, K. M., Choi, S. H., Lim, S., Park, K. S., Kim, K. W., & Jang, H. C. (2016). Sarcopenia as a predictor of future cognitive impairment in older adults. The Journal of nutrition, health and aging. https://doi.org/10.1007/s12603-015-0613-x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.